Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Cormorant Asset Management
company
Investments
Number of Investments
Number of Lead Investments
21
3
Cormorant Asset Management has made 21 investments. Their most recent investment was on
Aug 12, 2022, when Greenlight Biosciences, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Aug 12, 2022 | Greenlight Biosciences | Post-IPO Equity | — | Agriculture | — |
| Apr 19, 2022 | Tessera Therapeutics | Series C | — | Biopharma | — |
| Feb 16, 2022 | Star Therapeutics | Series Unknown | — | — | |
| Feb 3, 2022 | Greenlight Biosciences | Post-IPO Equity | — | Agriculture | — |
| Jul 13, 2021 | Prime Medicine | Series B | — | Biotechnology | — |
| Mar 22, 2021 | EpimAb Biotherapeutics | Series C | — | Biopharma | — |
| Jan 19, 2021 | Beam Therapeutics | Post-IPO Equity | — | Biotechnology | — |
| Jan 19, 2021 | Verve Therapeutics | Series B | — | Biotechnology | — |
| Sep 28, 2020 | BioShin | Series A | — | Biotechnology | — |
| Aug 26, 2020 | Freenome | Series C | — | Biotechnology | — |
| Jun 16, 2020 | Greenlight Biosciences | Series D | — | Agriculture | — |
| Nov 13, 2019 | Avidity Biosciences | Series C | — | Biotechnology | — |
| Mar 6, 2019 | Beam Therapeutics | Series B | — | Biotechnology | — |
| Apr 25, 2018 | Corvidia | Series B | — | Biotechnology | — |
| Nov 16, 2017 | X4 Pharmaceuticals | Series B | — | Biotechnology | Yes |
| Sep 26, 2017 | Autolus | Series C | — | Biopharma | Yes |
| Sep 8, 2017 | Replimune Group | Series B | — | Biotechnology | — |
| Jul 18, 2016 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| Jan 19, 2016 | Twist Bioscience | Series D | — | Biotechnology | — |
| Dec 15, 2015 | X4 Pharmaceuticals | Series A | — | Biotechnology | Yes |
| Jun 22, 2015 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
